<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>amlodipine</title><link>http://www.unboundmedicine.com/medline/ebm/research/amlodipine</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Atrial Fibrillation at Baseline and During Follow-Up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).</title><link>http://www.unboundmedicine.com/medline/ebm/record/19926008/full_citation/Atrial_Fibrillation_at_Baseline_and_During_Follow_Up_in_ALLHAT__Antihypertensive_and_Lipid_Lowering_Treatment_to_Prevent_Heart_Attack_Trial__</link><description>Haywood LJ, Ford CE, Crow RS, et al. <br/><span class="title">Atrial Fibrillation at Baseline and During Follow-Up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial). [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of the American College of Cardiology">J Am Coll Cardiol 2009 Nov 24; 54(22):2023-2031.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19926008/abstract/Atrial_Fibrillation_at_Baseline_and_During_Follow_Up_in_ALLHAT__Antihypertensive_and_Lipid_Lowering_Treatment_to_Prevent_Heart_Attack_Trial__">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19926008/full_citation/Atrial_Fibrillation_at_Baseline_and_During_Follow_Up_in_ALLHAT__Antihypertensive_and_Lipid_Lowering_Treatment_to_Prevent_Heart_Attack_Trial__">Full Citation</a> | <a href="http://linkinghub.elsevier.com/retrieve/pii/S0735-1097(09)02924-6">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19926008/Atrial_Fibrillation_at_Baseline_and_During_Follow_Up_in_ALLHAT__Antihypertensive_and_Lipid_Lowering_Treatment_to_Prevent_Heart_Attack_Trial__">Find Related Articles</a> </description></item><item><title>Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19922890/full_citation/Results_of_a_Markov_model_analysis_to_assess_the_cost_effectiveness_of_a_single_tablet_of_fixed_dose_amlodipine_and_atorvastatin_for_the_primary_prevention_of_cardiovascular_disease_in_Korea_</link><description>Liew D, Park HJ, Ko SK <br/><span class="title">Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea. [JOURNAL ARTICLE]</span><br/><span class="source" title="Clinical therapeutics">Clin Ther 2009 Oct; 31(10):2189-2203.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19922890/abstract/Results_of_a_Markov_model_analysis_to_assess_the_cost_effectiveness_of_a_single_tablet_of_fixed_dose_amlodipine_and_atorvastatin_for_the_primary_prevention_of_cardiovascular_disease_in_Korea_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19922890/full_citation/Results_of_a_Markov_model_analysis_to_assess_the_cost_effectiveness_of_a_single_tablet_of_fixed_dose_amlodipine_and_atorvastatin_for_the_primary_prevention_of_cardiovascular_disease_in_Korea_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19922890/Results_of_a_Markov_model_analysis_to_assess_the_cost_effectiveness_of_a_single_tablet_of_fixed_dose_amlodipine_and_atorvastatin_for_the_primary_prevention_of_cardiovascular_disease_in_Korea_">Find Related Articles</a> </description></item><item><title>Amlodipine effects on vasomotion in rabbit external ophthalmic artery.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19921236/full_citation/Amlodipine_effects_on_vasomotion_in_rabbit_external_ophthalmic_artery_</link><description>Delgado E, Marques-Neves C, Rocha I, et al. <br/><span class="title">Amlodipine effects on vasomotion in rabbit external ophthalmic artery. [JOURNAL ARTICLE]</span><br/><span class="source" title="Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie">Graefes Arch Clin Exp Ophthalmol 2009 Nov 17.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19921236/abstract/Amlodipine_effects_on_vasomotion_in_rabbit_external_ophthalmic_artery_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19921236/full_citation/Amlodipine_effects_on_vasomotion_in_rabbit_external_ophthalmic_artery_">Full Citation</a></description></item><item><title>[Which role for calcium antagonists in the treatment of arterial hypertension after the ACCOMPLISH study?]</title><link>http://www.unboundmedicine.com/medline/ebm/record/19911691/full_citation/[Which_role_for_calcium_antagonists_in_the_treatment_of_arterial_hypertension_after_the_ACCOMPLISH_study]</link><description>Mottu I, Perrier A <br/><span class="title">[Which role for calcium antagonists in the treatment of arterial hypertension after the ACCOMPLISH study?] [English Abstract, Journal Article]</span><br/><span class="source" title="Revue médicale suisse">Rev Med Suisse 2009 Oct 14; 5(221):2045-8.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19911691/abstract/[Which_role_for_calcium_antagonists_in_the_treatment_of_arterial_hypertension_after_the_ACCOMPLISH_study]">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19911691/full_citation/[Which_role_for_calcium_antagonists_in_the_treatment_of_arterial_hypertension_after_the_ACCOMPLISH_study]">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19911691/[Which_role_for_calcium_antagonists_in_the_treatment_of_arterial_hypertension_after_the_ACCOMPLISH_study]">Find Related Articles</a> </description></item><item><title>CYP3A4 and CYP3A5 Polymorphisms and Blood Pressure Response to Amlodipine among African-American Men and Women with Early Hypertensive Renal Disease.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19907160/full_citation/CYP3A4_and_CYP3A5_Polymorphisms_and_Blood_Pressure_Response_to_Amlodipine_among_African_American_Men_and_Women_with_Early_Hypertensive_Renal_Disease_</link><description>Bhatnagar V, Garcia EP, O'Connor DT, et al. <br/><span class="title">CYP3A4 and CYP3A5 Polymorphisms and Blood Pressure Response to Amlodipine among African-American Men and Women with Early Hypertensive Renal Disease. [JOURNAL ARTICLE]</span><br/><span class="source" title="American journal of nephrology">Am J Nephrol 2009 Nov 12; 31(2):95-103.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19907160/abstract/CYP3A4_and_CYP3A5_Polymorphisms_and_Blood_Pressure_Response_to_Amlodipine_among_African_American_Men_and_Women_with_Early_Hypertensive_Renal_Disease_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19907160/full_citation/CYP3A4_and_CYP3A5_Polymorphisms_and_Blood_Pressure_Response_to_Amlodipine_among_African_American_Men_and_Women_with_Early_Hypertensive_Renal_Disease_">Full Citation</a></description></item><item><title>Effects of Olmesartan, an Angiotensin II Receptor Blocker, and Amlodipine, a Calcium Channel Blocker, on Cardio-Ankle Vascular Index (CAVI) in Type 2 Diabetic Patients with Hypertension.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19907103/full_citation/Effects_of_Olmesartan_an_Angiotensin_II_Receptor_Blocker_and_Amlodipine_a_Calcium_Channel_Blocker_on_Cardio_Ankle_Vascular_Index__CAVI__in_Type_2_Diabetic_Patients_with_Hypertension_</link><description>Miyashita Y, Saiki A, Endo K, et al. <br/><span class="title">Effects of Olmesartan, an Angiotensin II Receptor Blocker, and Amlodipine, a Calcium Channel Blocker, on Cardio-Ankle Vascular Index (CAVI) in Type 2 Diabetic Patients with Hypertension. [Journal Article]</span><br/><span class="source" title="Journal of atherosclerosis and thrombosis">J Atheroscler Thromb 2009 Oct; 16(5):621-6.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19907103/abstract/Effects_of_Olmesartan_an_Angiotensin_II_Receptor_Blocker_and_Amlodipine_a_Calcium_Channel_Blocker_on_Cardio_Ankle_Vascular_Index__CAVI__in_Type_2_Diabetic_Patients_with_Hypertension_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19907103/full_citation/Effects_of_Olmesartan_an_Angiotensin_II_Receptor_Blocker_and_Amlodipine_a_Calcium_Channel_Blocker_on_Cardio_Ankle_Vascular_Index__CAVI__in_Type_2_Diabetic_Patients_with_Hypertension_">Full Citation</a></description></item><item><title>Cardiovascular Effects of Azelnidipine in Comparison with Those of Amlodipine Assessed in the Halothane-Anaesthetized Dog.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19906049/full_citation/Cardiovascular_Effects_of_Azelnidipine_in_Comparison_with_Those_of_Amlodipine_Assessed_in_the_Halothane_Anaesthetized_Dog_</link><description>Ishizaka T, Takahara A, Iwasaki H, et al. <br/><span class="title">Cardiovascular Effects of Azelnidipine in Comparison with Those of Amlodipine Assessed in the Halothane-Anaesthetized Dog. [JOURNAL ARTICLE]</span><br/><span class="source" title="Basic &amp; clinical pharmacology &amp; toxicology">Basic Clin Pharmacol Toxicol 2009 Nov 9.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19906049/abstract/Cardiovascular_Effects_of_Azelnidipine_in_Comparison_with_Those_of_Amlodipine_Assessed_in_the_Halothane_Anaesthetized_Dog_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19906049/full_citation/Cardiovascular_Effects_of_Azelnidipine_in_Comparison_with_Those_of_Amlodipine_Assessed_in_the_Halothane_Anaesthetized_Dog_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19906049/Cardiovascular_Effects_of_Azelnidipine_in_Comparison_with_Those_of_Amlodipine_Assessed_in_the_Halothane_Anaesthetized_Dog_">Find Related Articles</a> </description></item><item><title>Randomized study to compare valsartan +/- HCTZ versus amlodipine +/- HCTZ strategies to maximize blood pressure control.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19898644/full_citation/Randomized_study_to_compare_valsartan_+/__HCTZ_versus_amlodipine_+/__HCTZ_strategies_to_maximize_blood_pressure_control_</link><description>Zappe D, Papst CC, Ferber P <br/><span class="title">Randomized study to compare valsartan +/- HCTZ versus amlodipine +/- HCTZ strategies to maximize blood pressure control. [Journal Article]</span><br/><span class="source" title="Vascular health and risk management">Vasc Health Risk Manag 2009.:883-92.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19898644/abstract/Randomized_study_to_compare_valsartan_+/__HCTZ_versus_amlodipine_+/__HCTZ_strategies_to_maximize_blood_pressure_control_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19898644/full_citation/Randomized_study_to_compare_valsartan_+/__HCTZ_versus_amlodipine_+/__HCTZ_strategies_to_maximize_blood_pressure_control_">Full Citation</a></description></item><item><title>Comparative efficacy and safety of amlodipine/benazepril combination therapy and amlodipine monotherapy in severe hypertension.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19890370/full_citation/Comparative_efficacy_and_safety_of_amlodipine/benazepril_combination_therapy_and_amlodipine_monotherapy_in_severe_hypertension_</link><description>Izzo JL, Purkayastha D, Hall D, et al. <br/><span class="title">Comparative efficacy and safety of amlodipine/benazepril combination therapy and amlodipine monotherapy in severe hypertension. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of human hypertension">J Hum Hypertens 2009 Nov 5.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19890370/abstract/Comparative_efficacy_and_safety_of_amlodipine/benazepril_combination_therapy_and_amlodipine_monotherapy_in_severe_hypertension_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19890370/full_citation/Comparative_efficacy_and_safety_of_amlodipine/benazepril_combination_therapy_and_amlodipine_monotherapy_in_severe_hypertension_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19890370/Comparative_efficacy_and_safety_of_amlodipine/benazepril_combination_therapy_and_amlodipine_monotherapy_in_severe_hypertension_">Find Related Articles</a> </description></item><item><title>Spironolactone and Chlorthalidone in Uncontrolled Elderly Hypertensive Patients Treated with Calcium Antagonists and Angiotensin II Receptor-Blocker: Effects on Endothelial Function, Inflammation, and Oxidative Stress.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19886856/full_citation/Spironolactone_and_Chlorthalidone_in_Uncontrolled_Elderly_Hypertensive_Patients_Treated_with_Calcium_Antagonists_and_Angiotensin_II_Receptor_Blocker:_Effects_on_Endothelial_Function_Inflammation_and_Oxidative_Stress_</link><description>Yamanari H, Nakamura K, Miura D, et al. <br/><span class="title">Spironolactone and Chlorthalidone in Uncontrolled Elderly Hypertensive Patients Treated with Calcium Antagonists and Angiotensin II Receptor-Blocker: Effects on Endothelial Function, Inflammation, and Oxidative Stress. [Journal Article]</span><br/><span class="source" title="Clinical and experimental hypertension (New York, N.Y. : 1993)">Clin Exp Hypertens 2009 Oct; 31(7):585-94.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19886856/abstract/Spironolactone_and_Chlorthalidone_in_Uncontrolled_Elderly_Hypertensive_Patients_Treated_with_Calcium_Antagonists_and_Angiotensin_II_Receptor_Blocker:_Effects_on_Endothelial_Function_Inflammation_and_Oxidative_Stress_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19886856/full_citation/Spironolactone_and_Chlorthalidone_in_Uncontrolled_Elderly_Hypertensive_Patients_Treated_with_Calcium_Antagonists_and_Angiotensin_II_Receptor_Blocker:_Effects_on_Endothelial_Function_Inflammation_and_Oxidative_Stress_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19886856/Spironolactone_and_Chlorthalidone_in_Uncontrolled_Elderly_Hypertensive_Patients_Treated_with_Calcium_Antagonists_and_Angiotensin_II_Receptor_Blocker:_Effects_on_Endothelial_Function_Inflammation_and_Oxidative_Stress_">Find Related Articles</a> </description></item></channel></rss>